Maternal and Child Health Hospital of Hubei Province clinical trials
Maternal and Child Health Hospital of Hubei Province is the lead sponsor of 5 current clinical trials in our China register. 5 are recruiting patients now. All registered phases are Not applicable. The drugs named most often in its trials are Dexmedetomidine, Esketamine and Remimazolam. The most-studied condition is Adenotonsillectomy.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Maternal and Child Health Hospital of Hubei Province
5 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Comparison of Ciprofol and Propofol Under IoC1 and IoC2 Monitoring for Adenotonsillectomy
NCT06882980 · ClinicalTrials.gov ↗ · Adenotonsillectomy, Propofol, Ciprofol
|
Not applicable | Recruiting | 2025-02 | China |
|
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
NCT07050212 · ClinicalTrials.gov ↗ · Remimazolam, Dexmedetomidine, Esketamine
|
Not applicable | Recruiting | 2025-04 | China |
|
Research on the Effect of Noise Cancelling Headphones in Reducing Postoperative Pain
NCT06918470 · ClinicalTrials.gov ↗ · Noise Cancelling Headphones, Postoperative Pain
|
Not applicable | Recruiting | 2025-02 | China |
|
A Study on Application of Adjustable Headrest in Painless Curettage Surgery for Overweight and Obese Patients
NCT06929000 · ClinicalTrials.gov ↗ · Adjustable Headrests, Ventilation Function, Obese Patients
|
Not applicable | Recruiting | 2025-02 | China |
|
Therapy on Perioperative Anxiety and Pain in Patients
NCT06970431 · ClinicalTrials.gov ↗ · Music Therapy, Anxiety, Health Education
|
Not applicable | Recruiting | 2025-02 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Maternal and Child Health Hospital of Hubei Province trials
3 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Maternal and Child Health Hospital of Hubei Province trials
14 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 5 | 5 |
A trial with sites in more than one country appears in each of those registers.
Questions about Maternal and Child Health Hospital of Hubei Province trials
How many clinical trials does Maternal and Child Health Hospital of Hubei Province sponsor?
Maternal and Child Health Hospital of Hubei Province is the lead sponsor of 5 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.
Are Maternal and Child Health Hospital of Hubei Province trials recruiting?
Yes. 5 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Maternal and Child Health Hospital of Hubei Province testing?
Its current trials name 3 drugs and biologicals as interventions. The most frequent are Dexmedetomidine (1), Esketamine (1) and Remimazolam (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.